PMID: 6143004Feb 4, 1984Paper

Why does plasma low density lipoprotein concentration in adults increase with age?

Lancet
N E Miller

Abstract

No abstract listed.

References

Mar 31, 1976·European Journal of Clinical Investigation·G SigurdssonB Lewis
Jun 17, 1976·The New England Journal of Medicine·M S Brown, J L Goldstein
Sep 1, 1976·Metabolism: Clinical and Experimental·C J PackardT D Lawrie
Nov 1, 1977·Metabolism: Clinical and Experimental·J L Goldstein, M S Brown
Mar 1, 1978·The Journal of Clinical Investigation·M F ReardonP J Nestel
Jan 1, 1979·Metabolism: Clinical and Experimental·J G BrookH A Feldman
May 1, 1979·The Journal of Clinical Endocrinology and Metabolism·A ChaitJ J Albers
May 1, 1979·Metabolism: Clinical and Experimental·P J NestelN H Fidge
Aug 1, 1979·The Journal of Clinical Investigation·D W BilheimerS M Grundy
Jul 1, 1978·The American Journal of Clinical Nutrition·W E ConnorH R Casdorph
Jun 1, 1972·The Journal of Clinical Investigation·T LangerR I Levy
Apr 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·G R ThompsonN B Myant
Nov 1, 1981·The Journal of Clinical Investigation·R W MahleyK H Weisgraber
Apr 1, 1983·The Journal of Clinical Investigation·Y A KesaniemiU P Steinbrecher
Jul 1, 1983·The Journal of Clinical Investigation·C J PackardJ Shepherd
Jul 1, 1983·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·D Steinberg
May 1, 1983·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·R D AbbottC LaRue
Jul 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·D W BilheimerJ L Goldstein
Jan 1, 1983·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·Y A Kesaniemi, S M Grundy
Mar 1, 1983·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·Y A Kesaniemi, S M Grundy
May 1, 1983·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·H GinsbergW V Brown
Jul 1, 1982·The Journal of Clinical Investigation·Y A Kesaniemi, S M Grundy
May 29, 1980·The New England Journal of Medicine·J ShepherdH G Morgan
Mar 1, 1980·Metabolism: Clinical and Experimental·C J PackardO D Taunton
Dec 22, 1962·Lancet·A G SHAPER, K W JONES

❮ Previous
Next ❯

Citations

Jan 1, 1990·European Journal of Applied Physiology and Occupational Physiology·I FreyJ Keul
Sep 1, 1991·Aging : Clinical and Experimental Research·S Calandra, P Tarugi
Jul 3, 2002·Aging Clinical and Experimental Research·Rosita TrottiGianvico Melzi d'Eril
Dec 21, 2000·Current Atherosclerosis Reports·K D Hecker St Jeor S
Dec 21, 2000·Current Atherosclerosis Reports·E Bruckert
Apr 15, 1988·Biochimica Et Biophysica Acta·M N Nanjee, N E Miller
Jul 1, 1993·Experimental Gerontology·L I KatzelA P Goldberg
May 13, 2005·Mechanisms of Ageing and Development·Chhanda BoseKodetthoor B Udupa
Dec 1, 1990·Baillière's Clinical Endocrinology and Metabolism·D Crook, M Seed
Aug 1, 1987·Baillière's Clinical Endocrinology and Metabolism·S M Grundy
Apr 19, 2002·Journal of Photochemistry and Photobiology. B, Biology·A K Haylett, J V Moore
Aug 3, 1999·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·M RudlingB Angelin
Sep 1, 2005·Journal of Palliative Medicine·Annette M VollrathJames Hallenbeck
Feb 1, 1991·The Journal of Clinical Investigation·S EricssonB Angelin
Sep 1, 1988·Atherosclerosis·H Gylling, T A Miettinen
Feb 1, 1987·American Heart Journal·Y A KesäniemiT A Miettinen
Apr 1, 1988·Atherosclerosis·N E MillerJ J Albers
Nov 1, 1985·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·S M GrundyD W Bilheimer
May 1, 1994·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·H GyllingT A Miettinen
Feb 1, 1990·Circulation·S M Grundy, G L Vega
Apr 9, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·P PariniM Rudling
Sep 15, 1984·British Medical Journal·A E Hill, M E Morgan
Jan 1, 1990·Annals of the New York Academy of Sciences·F M Sacks, B W Walsh
Jun 1, 1988·Scandinavian Journal of Clinical and Laboratory Investigation·A AhlgrenO Wisén
Jul 14, 2000·Journal of the American Geriatrics Society·S IwaoR Andres
Jul 24, 2014·Physiological Reports·Jonathan P PollockMatthew D Muller
Jul 1, 2014·Expert Review of Endocrinology & Metabolism·Mark T Mc Auley, Kathleen M Mooney
Jan 1, 1985·Acta Medica Scandinavica. Supplementum·S M GrundyY A Kesäniemi
Apr 9, 2013·Journal of Lipid Research·Zhenze ZhaoPeter Michaely
Jan 1, 1993·Metabolism: Clinical and Experimental·M M Cobb, N Risch
Nov 1, 1986·Metabolism: Clinical and Experimental·K K WillcoxD D Williams
Aug 1, 1985·The American Journal of Medicine·E R Eichner

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.